Trial Profile
Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Early Nephrotoxicity and/or Hypertension Due to Tacrolimus
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 03 Apr 2023
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- 21 Apr 2016 Primary endpoint has been changed. Also trial focus has changed from AR to PK.
- 12 Nov 2012 New trial record